Related references
Note: Only part of the references are listed.Heart Disease and Stroke Statistics-2011 Update A Report From the American Heart Association
Veronique L. Roger et al.
CIRCULATION (2011)
S100A1 GENETICALLY TARGETED THERAPY REVERSES DYSFUNCTION OF HUMAN FAILING MYOCARDIUM
Henriette L. Brinks et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Effect of Spironolactone on Left Ventricular Ejection Fraction and Volumes in Patients With Class I or II Heart Failure
Enrico Vizzardi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Systolic Heart Failure
John J. V. McMurray
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Lack of S100A1 in mice confers a gender-dependent hypertensive phenotype and increased mortality after myocardial infarction
Jean-Francois Desjardins et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Large Animal Models of Heart Failure A Critical Link in the Translation of Basic Science to Clinical Practice
Jennifer A. Dixon et al.
CIRCULATION-HEART FAILURE (2009)
Ca2+ signaling in mouse cardiomyocytes with ablated S100A1 protein
Konstantin Gusev et al.
GENERAL PHYSIOLOGY AND BIOPHYSICS (2009)
S100A1 in cardiovascular health and disease: Closing the gap between basic science and clinical therapy
Carolin Kraus et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure
Roger J. Hajjar et al.
JOURNAL OF CARDIAC FAILURE (2008)
Targeting myocardial β-adrenergic receptor signaling and calcium cycling for heart failure gene therapy
Sven T. Pleger et al.
JOURNAL OF CARDIAC FAILURE (2007)
Ca2+-dependent interaction of S100A1 with F1-ATPase leads to an increased ATP content in cardiomyocytes
Melanie Boerries et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue
Sven T. Pleger et al.
CIRCULATION (2007)
Principles of genetic murine models for cardiac disease
Katherine E. Yutzey et al.
CIRCULATION (2007)
S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes
Mirko Voelkers et al.
CELL CALCIUM (2007)
Review of current and investigational pharmacologic agents for acute heart failure syndromes
David D. Shin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction
Patrick Most et al.
CIRCULATION (2006)
Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors
OJ Müller et al.
CARDIOVASCULAR RESEARCH (2006)
S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction
ST Pleger et al.
MOLECULAR THERAPY (2005)
Energy metabolism in heart failure
R Ventura-Clapier et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
Cardiac adenoviral S100A1 gene delivery rescues failing myocardium
P Most et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia
G von Degenfeld et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance
P Most et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors
OJ Müller et al.
NATURE BIOTECHNOLOGY (2003)
Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart
R Bekeredjian et al.
CIRCULATION (2003)
Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human
K Haghighi et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
The myocardial protein S100A1 plays a role in the maintenance of normal gene expression in the adult heart
JN Tsoporis et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Cardiac energy metabolism homeostasis: Role of cytosolic calcium
RS Balaban
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
Transgenic rabbits expressing mutant essential light chain do not develop hypertrophic cardiomyopathy
J James et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice
XJ Du et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
S100A1:: A regulator of myocardial contractility
P Most et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Inotropic therapy for heart failure: An evidence-based approach
GM Felker et al.
AMERICAN HEART JOURNAL (2001)
Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure
BA Groenning et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction:: a systematic overview of data from individual patients
MD Flather et al.
LANCET (2000)
Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy -: The randomized evaluation of strategies for left ventricular dysfunction pilot study
W Cirillo et al.
CIRCULATION (2000)
Functional consequences of altering myocardial adrenergic receptor signaling
WJ Koch et al.
ANNUAL REVIEW OF PHYSIOLOGY (2000)
Share Paper
